Wellcome Open Research (Jul 2023)

Team based collaborative care model, facilitated by mHealth enabled and trained nurses, for management of heart failure with reduced ejection fraction in India (TIME-HF): design and rationale of a parallel group, open label, multi-centric cluster randomised controlled trial [version 2; peer review: 2 approved]

  • Sajan Ahmad,
  • Rajeev Edakutty,
  • Eapen Punnoose,
  • Sunu C Thomas,
  • Shafeeq Mattummal,
  • Johny Joseph,
  • N Syam,
  • Sunil Pisharody,
  • Veena Nanjappa,
  • Stigi Joseph,
  • Tiny Nair,
  • Vijo George,
  • Vijayan Ganesan,
  • Sivadasanpillai Harikrishnan,
  • Susanna Chacko,
  • Sanjay Ganapathi,
  • Jabir Abdullakutty,
  • Panniyammakal Jeemon,
  • Devaraju Chandgalu Javaregowda,
  • Charantharalyil Gopalan Bahuleyan,
  • Govindan Unni,
  • Gopalan Rajendiran,
  • Justin Paul Gnanaraj,
  • Jayakumar Balakrishnan,
  • Meera R Pillai,
  • Madhu Sreedharan,
  • Paul Thomas,
  • Neenumol KR,
  • Rachel Daniel,
  • Placid Sebastian

Journal volume & issue
Vol. 8

Abstract

Read online

Background: Heart failure (HF) is a debilitating condition associated with enormous public health burden. Management of HF is complex as it requires care-coordination with different cadres of health care providers. We propose to develop a team based collaborative care model (CCM), facilitated by trained nurses, for management of HF with the support of mHealth and evaluate its acceptability and effectiveness in Indian setting. Methods: The proposed study will use mixed-methods research. Formative qualitative research will identify barriers and facilitators for implementing CCM for the management of HF. Subsequently, a cluster randomised controlled trial (RCT) involving 22 centres (tertiary-care hospitals) and more than 1500 HF patients will be conducted to assess the efficacy of the CCM in improving the overall survival as well as days alive and out of hospital (DAOH) at two-years (CTRI/2021/11/037797). The DAOH will be calculated by subtracting days in hospital and days from death until end of study follow-up from the total follow-up time. Poisson regression with a robust variance estimate and an offset term to account for clustering will be employed in the analyses of DAOH. A rate ratio and its 95% confidence interval (CI) will be estimated. The scalability of the proposed intervention model will be assessed through economic analyses (cost-effectiveness) and the acceptability of the intervention at both the provider and patient level will be understood through both qualitative and quantitative process evaluation methods. Potential Impact: The TIME-HF trial will provide evidence on whether a CCM with mHealth support is effective in improving the clinical outcomes of HF with reduced ejection fraction in India. The findings may change the practice of management of HF in low and middle-income countries.

Keywords